Extracellular microRNAs are dynamic non-vesicular biomarkers of muscle turnover

Nucleic Acids Research

Volumn 41, Issue 20, 2013, Pages 9500-9513

  Roberts, Thomas C ^a,b   Godfrey, Caroline ^a   McClorey, Graham ^a   Vader, Pieter ^a   Briggs, Deborah ^c   Gardiner, Chris ^d   Aoki, Yoshitsugu ^a   Sargent, Ian ^d   Morgan, Jennifer E ^c   Wood, Matthew J A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROPHIN; DYSTROPHY ASSOCIATED MICRORNA; MICRORNA; MYOGENIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CELL VACUOLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; GENE EXPRESSION; GENETIC CORRELATION; MALE; MOUSE; MUSCLE INJURY; MUSCLE METABOLISM; MUSCLE REGENERATION; MUSCULAR DYSTROPHY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RNA ANALYSIS; TIBIALIS ANTERIOR MUSCLE; TISSUE DISTRIBUTION; UPREGULATION; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ANIMALS; BIOLOGICAL MARKERS; BLOOD PROTEINS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MICRORNAS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; REGENERATION;

EID: 84885354603     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt724     Document Type: Article

References (52)

1. Hoffman, E.P., Brown, R.H. Jr and Kunkel, L.M. (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell, 51, 919-928.
2. Arechavala-Gomeza, V., Anthony, K., Morgan, J. and Muntoni, F. (2012) Antisense oligonucleotide-mediated exon skipping for Duchenne muscular dystrophy: progress and challenges. Curr. Gene. Ther., 12, 152-160.
3. Betts, C., Saleh, A.F., Arzumanov, A.A., Hammond, S.M., Godfrey, C., Coursindel, T., Gait, M.J. and Wood, M.J. (2012) Pip6- PMO, A New Generation of Peptide-oligonucleotide Conjugates With Improved Cardiac Exon Skipping Activity for DMD Treatment. Mol. Ther. Nucleic Acids, 1, e38.
4. Goemans, N.M., Tulinius, M., van den Akker, J.T., Burm, B.E., Ekhart, P.F., Heuvelmans, N., Holling, T., Janson, A.A., Platenburg, G.J., Sipkens, J.A. et al. (2011) Systemic administration of PRO051 in Duchenne's muscular dystrophy. N. Engl. J. Med., 364, 1513-1522.
5. Cirak, S., Arechavala-Gomeza, V., Guglieri, M., Feng, L., Torelli, S., Anthony, K., Abbs, S., Garralda, M.E., Bourke, J., Wells, D.J. et al. (2011) Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, doseescalation study. Lancet, 378, 595-605.
6. Muntoni, F. and Wood, M.J.A. (2011) Targeting RNA to treat neuromuscular disease. Nat. Rev. Drug Discov., 10, 621-637.
7. Filipowicz, W., Jaskiewicz, L., Kolb, F.A. and Pillai, R.S. (2005) Post-transcriptional gene silencing by siRNAs and miRNAs. Curr. Opin. Struct. Biol, 15, 331-341.
8. Greco, S., De Simone, M., Colussi, C., Zaccagnini, G., Fasanaro, P., Pescatori, M., Cardani, R., Perbellini, R., Isaia, E., Sale, P. et al. (2009) Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia. FASEB J., 23, 3335-3346.
9. Russo, F., Di Bella, S., Nigita, G., Macca, V., Laganà, A., Giugno, R., Pulvirenti, A. and Ferro, A. (2012) miRandola: extracellular circulating microRNAs database. PLoS One, 7, e47786.
10. Mitchell, P.S., Parkin, R.K., Kroh, E.M., Fritz, B.R., Wyman, S.K., Pogosova-Agadjanyan, E.L., Peterson, A., Noteboom, J., O'Briant, K.C., Allen, A. et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl Acad. Sci. USA, 105, 10513-10518.
11. Gilad, S., Meiri, E., Yogev, Y., Benjamin, S., Lebanony, D., Yerushalmi, N., Benjamin, H., Kushnir, M., Cholakh, H., Melamed, N. et al. (2008) Serum microRNAs are promising novel biomarkers. PLoS One, 3, e3148.
12. Roberts, T.C., Blomberg, K.E.M., McClorey, G., Andaloussi, S.E., Godfrey, C., Betts, C., Coursindel, T., Gait, M.J., Smith, C.E. and Wood, M.J. (2012) Expression Analysis in Multiple Muscle Groups and Serum Reveals Complexity in the MicroRNA Transcriptome of the mdx Mouse with Implications for Therapy. Mol. Ther. Nucleic Acids, 1, e39.
13. Cacchiarelli, D., Legnini, I., Martone, J., Cazzella, V., D'Amico, A., Bertini, E. and Bozzoni, I. (2011) miRNAs as serum biomarkers for Duchenne muscular dystrophy. EMBO Mol. Med., 3, 258-265.
14. Mizuno, H., Nakamura, A., Aoki, Y., Ito, N., Kishi, S., Yamamoto, K., Sekiguchi, M., Takeda, S. and Hashido, K. (2011) Identification of muscle-specific microRNAs in serum of muscular dystrophy animal models: promising novel blood-based markers for muscular dystrophy. PLoS One, 6, e18388.
15. Goyenvalle, A., Babbs, A., Wright, J., Wilkins, V., Powell, D., Garcia, L. and Davies, K.E. (2012) Rescue of severely affected dystrophin/utrophin- deficient mice through scAAV-U7snRNAmediated exon skipping. Hum. Mol. Genet., 21, 2559-2571.
16. Pfaffl, M.W. (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res., 29, e45.
17. Andersen, C.L., Jensen, J.L. and Ørntoft, T.F. (2004) Normalization of real-time quantitative reverse transcription-PCR data: a modelbased variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res., 64, 5245-5250.
18. Mestdagh, P., Van Vlierberghe, P., De Weer, A., Muth, D., Westermann, F., Speleman, F. and Vandesompele, J. (2009) A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol., 10, R64.
19. Ruijter, J.M., Ramakers, C., Hoogaars, W.M.H., Karlen, Y., Bakker, O., van den Hoff, M.J.B. and Moorman, A.F.M. (2009) Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data. Nucleic Acids Res., 37, e45.
20. Ramakers, C., Ruijter, J.M., Deprez, R.H.L. and Moorman, A.F.M. (2003) Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci. Lett., 339, 62-66.
21. Blondal, T., Jensby Nielsen, S., Baker, A., Andreasen, D., Mouritzen, P., Wrang Teilum, M. and Dahlsveen, I.K. (2013) Assessing sample and miRNA profile quality in serum and plasma or other biofluids. Methods, 59, S1-6.
22. Gardiner, C., Ferreira, Y.J., Dragovic, R.A., Redman, C.W.G. and Sargent, I.L. (2013) Extracellular vesicle sizing and enumeration by nanoparticle tracking analysis. J. Extracellular Vesicles, 2, 19671.
23. Arechavala-Gomeza, V., Kinali, M., Feng, L., Brown, S.C., Sewry, C., Morgan, J.E. and Muntoni, F. (2010) Immunohistological intensity measurements as a tool to assess sarcolemma-associated protein expression. Neuropathol. Appl. Neurobiol., 36, 265-274.
24. Saeed, A.I., Sharov, V., White, J., Li, J., Liang, W., Bhagabati, N., Braisted, J., Klapa, M., Currier, T., Thiagarajan, M. et al. (2003) TM4: a free, open-source system for microarray data management and analysis. BioTechniques, 34, 374-378.
25. Coulton, G.R., Morgan, J.E., Partridge, T.A. and Sloper, J.C. (1988) The mdx mouse skeletal muscle myopathy: I. A histological, morphometric and biochemical investigation. Neuropathol. Appl. Neurobiol., 14, 53-70.
26. Hawke, T.J. and Garry, D.J. (2001) Myogenic satellite cells: physiology to molecular biology. J. Appl. Physiol., 91, 534-551.
27. Tsui, N.B.Y., Ng, E.K.O. and Lo, Y.M.D. (2002) Stability of endogenous and added RNA in blood specimens, serum, and plasma. Clin. Chem., 48, 1647-1653.
28. Kosaka, N., Iguchi, H., Yoshioka, Y., Takeshita, F., Matsuki, Y. and Ochiya, T. (2010) Secretory mechanisms and intercellular transfer of microRNAs in living cells. J. Biol. Chem., 285, 17442-17452.
29. Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J.J. and Lötvall, J.O. (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol., 9, 654-659.
30. Zernecke, A., Bidzhekov, K., Noels, H., Shagdarsuren, E., Gan, L., Denecke, B., Hristov, M., Köppel, T., Jahantigh, M.N., Lutgens, E. et al. (2009) Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci. Signal., 2, ra81.
31. Arroyo, J.D., Chevillet, J.R., Kroh, E.M., Ruf, I.K., Pritchard, C.C., Gibson, D.F., Mitchell, P.S., Bennett, C.F., Pogosova-Agadjanyan, E.L., Stirewalt, D.L. et al. (2011) Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc. Natl Acad. Sci. USA, 108, 5003-5008.
32. Turchinovich, A. and Burwinkel, B. (2012) Distinct AGO1 and AGO2 associated miRNA profiles in human cells and blood plasma. RNA Biol., 9.
33. Wang, K., Zhang, S., Weber, J., Baxter, D. and Galas, D.J. (2010) Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res., 38, 7248-7259.
34. Vickers, K.C., Palmisano, B.T., Shoucri, B.M., Shamburek, R.D. and Remaley, A.T. (2011) MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat. Cell Biol., 13, 423-433.
35. Turchinovich, A., Weiz, L., Langheinz, A. and Burwinkel, B. (2011) Characterization of extracellular circulating microRNA. Nucleic Acids Res., 39, 7223-7233.
36. El-Hefnawy, T., Raja, S., Kelly, L., Bigbee, W.L., Kirkwood, J.M., Luketich, J.D. and Godfrey, T.E. (2004) Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics. Clin. Chem., 50, 564-573.
37. Zhang, Y., Liu, D., Chen, X., Li, J., Li, L., Bian, Z., Sun, F., Lu, J., Yin, Y., Cai, X. et al. (2010) Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol. Cell, 39, 133-144.
38. Gagan, J., Dey, B.K., Layer, R., Yan, Z. and Dutta, A. (2011) MicroRNA-378 targets the myogenic repressor MyoR during myoblast differentiation. J. Biol. Chem., 286, 19431-19438.
39. Soleimani, V.D., Yin, H., Jahani-Asl, A., Ming, H., Kockx, C.E.M., van Ijcken, W.F.J., Grosveld, F. and Rudnicki, M.A. (2012) Snail regulates MyoD binding-site occupancy to direct enhancer switching and differentiation-specific transcription in myogenesis. Mol. Cell, 47, 457-468.
40. Gurha, P., Abreu-Goodger, C., Wang, T., Ramirez, M.O., Drumond, A.L., van Dongen, S., Chen, Y., Bartonicek, N., Enright, A.J., Lee, B. et al. (2012) Targeted deletion of microRNA- 22 promotes stress-induced cardiac dilation and contractile dysfunction. Circulation, 125, 2751-2761.
41. Kim, H.K., Lee, Y.S., Sivaprasad, U., Malhotra, A. and Dutta, A. (2006) Muscle-specific microRNA miR-206 promotes muscle differentiation. J. Cell Biol., 174, 677-687.
42. Chen, J.-F., Mandel, E.M., Thomson, J.M., Wu, Q., Callis, T.E., Hammond, S.M., Conlon, F.L. and Wang, D.-Z. (2006) The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet., 38, 228-233.
43. Yuasa, K., Hagiwara, Y., Ando, M., Nakamura, A., Takeda, S. and Hijikata, T. (2008) MicroRNA-206 is highly expressed in newly formed muscle fibers: implications regarding potential for muscle regeneration and maturation in muscular dystrophy. Cell Struct. Funct., 33, 163-169.
44. Liu, N., Williams, A.H., Maxeiner, J.M., Bezprozvannaya, S., Shelton, J.M., Richardson, J.A., Bassel-Duby, R. and Olson, E.N. (2012) microRNA-206 promotes skeletal muscle regeneration and delays progression of Duchenne muscular dystrophy in mice. J. Clin. Invest., 122, 2054-2065.
45. Collins, C.A. and Morgan, J.E. (2003) Duchenne's muscular dystrophy: animal models used to investigate pathogenesis and develop therapeutic strategies. Int. J. Exp. Pathol., 84, 165-172.
46. Tanabe, Y., Esaki, K. and Nomura, T. (1986) Skeletal muscle pathology in X chromosome-linked muscular dystrophy (mdx) mouse. Acta. Neuropathologica, 69, 91-95.
47. Villalta, S.A., Nguyen, H.X., Deng, B., Gotoh, T. and Tidball, J.G. (2009) Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy. Hum. Mol. Genet., 18, 482-496.
48. Nielsen, M., Hansen, J.H., Hedegaard, J., Nielsen, R.O., Panitz, F., Bendixen, C. and Thomsen, B. (2010) MicroRNA identity and abundance in porcine skeletal muscles determined by deep sequencing. Anim. Genet., 41, 159-168.
49. Zhang, L., Hou, D., Chen, X., Li, D., Zhu, L., Zhang, Y., Li, J., Bian, Z., Liang, X., Cai, X. et al. (2012) Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of crosskingdom regulation by microRNA. Cell Res., 22, 107-126.
50. Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S. and Wood, M.J.A. (2011) Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat. Biotechnol., 29, 341-345.
51. Nakasa, T., Ishikawa, M., Shi, M., Shibuya, H., Adachi, N. and Ochi, M. (2010) Acceleration of muscle regeneration by local injection of muscle-specific microRNAs in rat skeletal muscle injury model. J. Cell. Mol. Med., 14, 2495-2505.
52. Lim, L.P., Lau, N.C., Garrett-Engele, P., Grimson, A., Schelter, J.M., Castle, J., Bartel, D.P., Linsley, P.S. and Johnson, J.M. (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature, 433, 769-773.